Mixed Stock Futures as Autodesk Partners with AWS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Autodesk Strategic Partnership: Autodesk announced a strategic partnership with Amazon Web Services (AWS) to offer Fusion and Fusion Manage products through AWS Marketplace starting in Q2, simplifying procurement and billing processes for customers while enhancing cloud-based design and engineering workflows.
- 3D Systems Financing Challenge: 3D Systems priced an upsized public offering of 16.4 million shares at $3.05 each, raising approximately $50 million, but the stock plummeted 15%, indicating market concerns about its future outlook despite the successful financing.
- Broadcom Earnings Beat: Broadcom reported an adjusted EPS of $2.44 and revenue of $22.19 billion, both exceeding expectations, yet shares fell 12%, reflecting investors' overly optimistic expectations for future growth despite strong AI-driven revenue increases.
- CrowdStrike Positive Outlook: CrowdStrike's Q1 revenue rose 26% year-over-year to $1.39 billion, with an adjusted EPS of $1.10, and although shares dropped 10%, the company raised its FY2027 revenue and earnings guidance, highlighting strong demand for its cybersecurity platform.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DDD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DDD
Wall Street analysts forecast DDD stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 3.880
Low
5.00
Averages
5.00
High
5.00
Current: 3.880
Low
5.00
Averages
5.00
High
5.00
About DDD
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Autodesk Strategic Partnership: Autodesk announced a strategic partnership with Amazon Web Services (AWS) to offer Fusion and Fusion Manage products through AWS Marketplace starting in Q2, simplifying procurement and billing processes for customers while enhancing cloud-based design and engineering workflows.
- 3D Systems Financing Challenge: 3D Systems priced an upsized public offering of 16.4 million shares at $3.05 each, raising approximately $50 million, but the stock plummeted 15%, indicating market concerns about its future outlook despite the successful financing.
- Broadcom Earnings Beat: Broadcom reported an adjusted EPS of $2.44 and revenue of $22.19 billion, both exceeding expectations, yet shares fell 12%, reflecting investors' overly optimistic expectations for future growth despite strong AI-driven revenue increases.
- CrowdStrike Positive Outlook: CrowdStrike's Q1 revenue rose 26% year-over-year to $1.39 billion, with an adjusted EPS of $1.10, and although shares dropped 10%, the company raised its FY2027 revenue and earnings guidance, highlighting strong demand for its cybersecurity platform.
See More
- Offering Size: 3D Systems announced an upsized public offering of 16,393,443 shares at a price of $3.05 per share, raising approximately $50 million, indicating a strong capital market financing need for the company.
- Underwriter Options: All shares are being offered by 3D Systems, with underwriters granted a 30-day option to purchase an additional 2,459,016 shares, enhancing market liquidity for the stock.
- Market Reaction: The stock fell approximately 15% in extended trading, reflecting a negative market response to the offering, which may impact investor confidence.
- Future Outlook: Despite current challenges, 3D Systems expects over 20% growth in aerospace and defense sectors in 2026, guiding Q2 revenue between $93 million and $95 million, demonstrating the company's confidence in future growth.
See More
- Offering Size: 3D Systems announced the pricing of an upsized public offering of 16,393,443 shares at $3.05 per share, aiming for gross proceeds of approximately $50 million, with the offering expected to close on June 5, 2026, reflecting the company's proactive financing strategy in the capital markets.
- Underwriter Arrangement: Needham & Company and Craig-Hallum are acting as joint book-running managers for the offering, indicating the company's professionalism and market credibility in selecting underwriters, which is likely to enhance investor confidence in its future growth.
- Additional Option: The company granted underwriters a 30-day option to purchase an additional 2,459,016 shares at the same price, providing flexibility for further financing and potentially increasing cash inflow if market demand remains strong.
- Registration Statement Validity: The registration statement related to this offering was declared effective by the SEC on May 27, 2026, ensuring transparency and legality in compliance, which helps to build investor trust.
See More
- Offering Launch: 3D Systems announced the commencement of a $40 million underwritten public offering of its common stock, indicating a proactive approach to capital markets.
- Over-Allotment Option: The company intends to grant underwriters a 30-day option to purchase up to an additional 15% of shares sold, aimed at addressing market demand fluctuations and enhancing issuance flexibility.
- Market Condition Impact: The offering is subject to market conditions and other factors, with 3D Systems cautioning investors that there is no assurance regarding the completion, size, or final terms of the offering, reflecting current market uncertainties.
- Growth Outlook: Despite market challenges, 3D Systems expects over 20% growth in its aerospace and defense segment by 2026, guiding Q2 revenue between $93 million and $95 million, showcasing the company's growth potential in specific sectors.
See More
- Profitability Signs: Craig-Hallum analyst Greg Palm raised the price target for 3D Systems Corporation from $2.50 to $3.00 while maintaining a Hold rating, citing early signs of profitability after years of losses.
- Significant Revenue Growth: In Q1 2026, 3D Systems reported revenue of $95.5 million, an 11% year-over-year increase, with the Healthcare Solutions segment leading at a 21% growth to $50.1 million, indicating strong market demand.
- Cost Control Success: The company implemented a substantial cost-cutting program in Q1, resulting in a 35% year-over-year reduction in non-GAAP operating expenses and locking in over $55 million in annualized savings, while non-GAAP gross margin improved to 36.1%, up 6 percentage points.
- Cautious Market Reaction: Despite the improved performance, analyst Palm noted that these results might be an outlier, as the stock did not react positively as expected, indicating market skepticism regarding the sustainability of the profitability trend.
See More

- IPO Milestone: Conexeu Sciences Inc. successfully debuted on Nasdaq on May 21, 2026, with 25,269,996 shares outstanding and a fully diluted total of 35,238,222 shares, marking a significant advancement in regenerative medicine and enhancing its market competitiveness.
- Innovative Product Launch: The company unveiled its 3D bioprinted regenerative breast matrix, B.R.E.A.S.T.™, designed to provide a temporary scaffold for patients post-mastectomy, targeting over 100,000 women annually who opt out of reconstruction, thus opening a larger market opportunity.
- Platform Advantage: Conexeu's CXU™ platform can be applied across multiple tissue regeneration products, streamlining product development processes and targeting multi-billion-dollar markets in wound care, periodontal applications, and facial contouring, indicating vast market potential.
- Regulatory Strategy: The company plans to submit a 510(k) application in early 2027, transitioning its products from investigational to commercial status, further solidifying its leadership position in the regenerative medicine sector.
See More










